BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17724303)

  • 21. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

  • 22. Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes.
    Yeh EA; Parrish JB; Weinstock-Guttman B
    Expert Rev Neurother; 2011 Mar; 11(3):433-40. PubMed ID: 21375448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
    Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller DH; Montalban X; Polman C; Rocca MA; Thompson AJ; Yousry TA; Filippi M
    Neurology; 2009 May; 72(19):1693-701. PubMed ID: 19433744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Towards a reliable prognosis for multiple sclerosis].
    Heinzlef O; Roullet E
    Rev Prat; 1999 Nov; 49(17):1872-5. PubMed ID: 10598503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis mimics.
    Herndon RM
    Adv Neurol; 2006; 98():161-6. PubMed ID: 16400833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of cortical lesions in MS: relation with cognitive impairment.
    Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
    Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging evaluation in multiple sclerosis.
    Rieumont MJ; DeLuca SA
    Am Fam Physician; 1993 Aug; 48(2):273-6. PubMed ID: 8342480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Benign multiple sclerosis].
    Winder G; Achiron A
    Harefuah; 2011 May; 150(5):463-5, 490, 489. PubMed ID: 21678644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign course in multiple sclerosis: a review.
    Ramsaransing GS; De Keyser J
    Acta Neurol Scand; 2006 Jun; 113(6):359-69. PubMed ID: 16674602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of multiple sclerosis].
    Brochet B
    Rev Prat; 1999 Nov; 49(17):1861-5. PubMed ID: 10598501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis between acute disseminated encephalomyelitis and multiple sclerosis during the first episode.
    Tavazzi E; Ravaglia S; Franciotta D; Marchioni E
    Arch Neurol; 2008 May; 65(5):676-7; author reply 677. PubMed ID: 18474751
    [No Abstract]   [Full Text] [Related]  

  • 35. No shortcuts to outcome in MS clinical trials?
    Koch-Henriksen N
    Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696
    [No Abstract]   [Full Text] [Related]  

  • 36. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatigue, depression and progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
    Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychiatric disorders in multiple sclerosis].
    GarcĂ­a-Moreno JM; Duque P; Izquierdo G
    Rev Neurol; 2001 Sep 16-30; 33(6):560-7. PubMed ID: 11727241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Illness perception and health-related quality of life in multiple sclerosis.
    Spain LA; Tubridy N; Kilpatrick TJ; Adams SJ; Holmes AC
    Acta Neurol Scand; 2007 Nov; 116(5):293-9. PubMed ID: 17850407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the concept of multiple sclerosis].
    Guseo A
    Orv Hetil; 1998 Nov; 139(48):2875-81. PubMed ID: 9868901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.